44 results on '"Kim, S.W."'
Search Results
2. Differential protein stability and clinical responses ofEML4-ALK fusion variants to various ALK inhibitors in advancedALK-rearranged non-small cell lung cancer
3. 245P Impact of regular intensive imaging surveillance on survival after recurrence in patients with early breast cancer; a propensity score matching study
4. 1655P Dabrafenib and trametinib in patients with metastatic BRAFV600E-mutated thyroid cancer
5. 588P Prognostic value of circulating tumor DNA (ctDNA) in ovarian cancer
6. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
7. 765P HER2 expression in ovarian cancer: Its relationship with HRD status, and other biomarkers
8. Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer
9. Response assessment by combined PET–CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy
10. P-134 Parthenolide suppresses hypoxia induced angiogenesis and epithelial-mesenchymal transition by regulating hypoxia inducible factor 1 &agr; signaling in colorectal cancer
11. P-002 Suppression of lipocalin-2 promotes the epithelial-to-mesenchymal transition in human colorectal cancer cells
12. 756P Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
13. 757P Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
14. A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
15. 312P Prediction model of breast cancer patient’s neoadjuvant treatment outcome using breast cancer organoids cultured from core needle biopsies
16. Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma
17. 591P Feasibility of longitudinal monitoring of whole blood-based circulating tumour DNA (ctDNA) in patients with endometrial cancer
18. 551P Genomic DNA analysis of cervical smear samples of endometrial cancer with next-generation sequencing: A prospective study
19. 5-years conditional disease free survival and overall survival for breast cancer patients in South Korea
20. Oncologic outcome of invasive lobular carcinoma: Is it different from that of invasive ductal carcinoma?
21. A phase Ib trial of neoadjuvant chemoradiotherapy and durvalumab (MEDI4736) for potentially resectable stage III non-small cell lung cancer (NSCLC)
22. Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytology proven axillary node-positive breast cancer at diagnosis
23. Multiplex immunoassays analysis of plasma biomarker levels and response to neoadjuvant chemotherapy for locally advanced breast cancer
24. Only estrogen receptor “positive” is not enough to predict the prognosis of breast cancer running head: Revisiting estrogen positive tumors in 8th AJCC staging era
25. 387P - 5-years conditional disease free survival and overall survival for breast cancer patients in South Korea
26. 1477TiP - A phase Ib trial of neoadjuvant chemoradiotherapy and durvalumab (MEDI4736) for potentially resectable stage III non-small cell lung cancer (NSCLC)
27. 265P - Oncologic outcome of invasive lobular carcinoma: Is it different from that of invasive ductal carcinoma?
28. 275P - Multiplex immunoassays analysis of plasma biomarker levels and response to neoadjuvant chemotherapy for locally advanced breast cancer
29. 262P - Use of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytology proven axillary node-positive breast cancer at diagnosis
30. 149P - Only estrogen receptor “positive” is not enough to predict the prognosis of breast cancer running head: Revisiting estrogen positive tumors in 8th AJCC staging era
31. 75P Does postmastectomy radiotherapy benefit breast cancer patients with 1-3 positive lymph nodes?
32. 54O Evaluation of BRCA1/2 mutation prevalence in Korean women with triple-negative breast cancer
33. A randomized, double-blind, placebo-controlled, phase III trial of erlotinib with or without a c-Met inhibitor tivantinib (ARQ 197) in Asian patients with previously treated stage IIIB/IV nonsquamous nonsmall-cell lung cancer harboring wild-type epidermal growth factor receptor (ATTENTION study)
34. Role of Follow Up Endoscopic Examinations in Response Assessment of Patients with Gastric Diffuse Large B Cell Lymphoma
35. Prognostic Outcomes of Concurrent GNRH Agonist Use with Chemotherapy
36. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)
37. The Treatment Options of Recurred Brain Metastasis after Prophylactic Cranial Irradiation in Patients with Small-Cell Lung Cancer
38. MMP-9 and Vegfr Expression has Prognostic Significance after Resection for Primary Tumor and Metastatic Site in Colorectal Cancer
39. A Randomized Phase 2 Study of Erlotinib Plus Pemetrexed vs Erlotinib or Pemetrexed Alone as Second-Line Treatment for Never-Smoker Patients with Non-Squamous Advanced Non-Small Cell Lung Cancer (NSCLC)
40. 960P - Role of Follow Up Endoscopic Examinations in Response Assessment of Patients with Gastric Diffuse Large B Cell Lymphoma
41. 6P - Prognostic Outcomes of Concurrent GNRH Agonist Use with Chemotherapy
42. P2-001 - The Treatment Options of Recurred Brain Metastasis after Prophylactic Cranial Irradiation in Patients with Small-Cell Lung Cancer
43. 1225O - A Randomized Phase 2 Study of Erlotinib Plus Pemetrexed vs Erlotinib or Pemetrexed Alone as Second-Line Treatment for Never-Smoker Patients with Non-Squamous Advanced Non-Small Cell Lung Cancer (NSCLC)
44. 545P - MMP-9 and Vegfr Expression has Prognostic Significance after Resection for Primary Tumor and Metastatic Site in Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.